NFJ Investment Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$39.3M Sell
1,398,757
-783,593
-36% -$20.9M 1.49% 17
2025
Q4
$54.3M Sell
2,182,350
-151,364
-6% -$3.82M 1.96% 9
2025
Q3
$59.5M Sell
2,333,714
-18,911
-0.8% -$467K 2.04% 6
2025
Q2
$57M Buy
2,352,625
+746,651
+46% +$17.4M 1.99% 9
2025
Q1
$40.7M Buy
1,605,974
+817,137
+104% +$21.4M 1.37% 17
2024
Q4
$20.9M Buy
788,837
+404,266
+105% +$11M 0.67% 53
2024
Q3
$11.1M Buy
384,571
+43,719
+13% +$1.28M 0.33% 89
2024
Q2
$9.54M Hold
340,852
0.29% 102
2024
Q1
$9.46M Hold
340,852
0.26% 106
2023
Q4
$9.81M Buy
+340,852
New +$10.3M 0.27% 100

Other funds holding PFE

NFJ Investment Group's PFE Position: Q1 2026 in Review

NFJ Investment Group reduced its Pfizer (PFE) stake by 36% in Q1 2026, selling an estimated $20.9M and leaving 1,398,757 shares worth $39.3M. The position accounts for 1.49% of the portfolio, ranked #17.

NFJ Investment Group first reported a position in PFE in Q4 2023 and has held it in 10 quarters since. The position peaked at $59.5M in Q3 2025. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • NFJ Investment Group held 1,398,757 shares of Pfizer worth $39.3M as of Q1 2026.
  • NFJ Investment Group sold 783,593 Pfizer shares in Q1 2026, an estimated $20.9M.
  • Pfizer made up 1.49% of NFJ Investment Group's portfolio in Q1 2026, its #17 holding.
  • NFJ Investment Group first reported a position in Pfizer in Q4 2023 and has held it in 10 quarters since.
  • NFJ Investment Group's Pfizer position peaked at $59.5M in Q3 2025.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on NFJ Investment Group's 13F filing for Q1 2026, filed 13 May 2026.